BUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资

路透中文

Jun 23

BUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资

6月22日 - ** UniQure NV QURE.O 计划筹集股权资金，此前仅数日，美国食品药品监督管理局（FDA）才推翻了其此前对这家荷兰制药公司亨廷顿病治疗药物的立场

** QURE (link) 启动1.5亿美元的股票及预先注资认股权证发行计划

** 周三，美国卫生监管机构表示将接受 (link) 现有的临床试验数据，对AMT-130进行加速审查，受此消息提振，该公司在美国上市的股票飙升约78%，收于48.16美元

** Leerink Partners与Stifel共同担任此次股票发行的联席簿记管理人

** 周一，在美国上市的QURE股价收跌4.1%，报44.39美元。在盘后交易中，该股上涨1.9%，报45.22美元

** QURE 流通股约为 6,310 万股，当前市值为 28 亿美元

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2645070748"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2645070748\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2645070748?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-06-23 04:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645070748","market":"hk","top_or_hot":-1,"title":"BUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资</title></head><body><p>\n<span>6月22日</span><span> - </span>** UniQure NV <span>QURE.O</span> 计划筹集股权资金，此前仅数日，<a href=\"https://laohu8.com/S/USFD\">美国食品</a>药品监督管理局（FDA）才推翻了其此前对这家荷兰制药公司亨廷顿病治疗药物的立场</p><p>** QURE (link) 启动1.5亿美元的股票及预先注资认股权证发行计划</p><p>** 周三，美国卫生监管机构表示将接受 (<span>link</span>) 现有的临床试验数据，对AMT-130进行加速审查，受此消息提振，该公司在美国上市的股票飙升约78%，收于48.16美元</p><p>** Leerink Partners与<a href=\"https://laohu8.com/S/SFB\">Stifel</a>共同担任此次股票发行的联席簿记管理人</p><p>** 周一，在美国上市的QURE股价收跌4.1%，报44.39美元。在盘后交易中，该股上涨1.9%，报45.22美元</p><p>** QURE 流通股约为 6,310 万股，当前市值为 28 亿美元</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-06-23 04:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资</title></head><body><p>\n<span>6月22日</span><span> - </span>** UniQure NV <span>QURE.O</span> 计划筹集股权资金，此前仅数日，<a href=\"https://laohu8.com/S/USFD\">美国食品</a>药品监督管理局（FDA）才推翻了其此前对这家荷兰制药公司亨廷顿病治疗药物的立场</p><p>** QURE (link) 启动1.5亿美元的股票及预先注资认股权证发行计划</p><p>** 周三，美国卫生监管机构表示将接受 (<span>link</span>) 现有的临床试验数据，对AMT-130进行加速审查，受此消息提振，该公司在美国上市的股票飙升约78%，收于48.16美元</p><p>** Leerink Partners与<a href=\"https://laohu8.com/S/SFB\">Stifel</a>共同担任此次股票发行的联席簿记管理人</p><p>** 周一，在美国上市的QURE股价收跌4.1%，报44.39美元。在盘后交易中，该股上涨1.9%，报45.22美元</p><p>** QURE 流通股约为 6,310 万股，当前市值为 28 亿美元</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4207","symbol_name":"综合性银行","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4T42U1NH:1","article_id":"2645070748","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645070748","pubTimestamp":1782161810,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"在盘后交易中，该股上涨1.9%，报45.22美元** QURE 流通股约为 6,310 万股，当前市值为 28 亿美元(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4207":"综合性银行","BK4127":"投资银行业与经纪业","MNSH":"MNSN HLDGS INC.","SF":"Stifel Financial Corp"},"translate_title":"Buzz-Uniqure launches $150M equity funding after FDA policy reversal","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNSH":0.9,"SF":0.9},"content_text":"BUZZ-在FDA政策逆转后，UniQure启动1.5亿美元的股权融资\n6月22日 - ** UniQure NV QURE.O 计划筹集股权资金，此前仅数日，美国食品药品监督管理局（FDA）才推翻了其此前对这家荷兰制药公司亨廷顿病治疗药物的立场** QURE (link) 启动1.5亿美元的股票及预先注资认股权证发行计划** 周三，美国卫生监管机构表示将接受 (link) 现有的临床试验数据，对AMT-130进行加速审查，受此消息提振，该公司在美国上市的股票飙升约78%，收于48.16美元** Leerink Partners与Stifel共同担任此次股票发行的联席簿记管理人** 周一，在美国上市的QURE股价收跌4.1%，报44.39美元。在盘后交易中，该股上涨1.9%，报45.22美元** QURE 流通股约为 6,310 万股，当前市值为 28 亿美元(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}